Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes.
Saved in:
| Title: | Cohort Study: Risk of Gallstones and Biliary Complications With Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes. |
|---|---|
| Authors: | Eldesouki MH; Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA., Alkasabrah O; Department of Internal Medicine, New York Medical College/Landmark Medical Center, Woonsocket, Rhode Island, USA., Kloub M; Department of Internal Medicine, New York Medical College at Saint Michael's Medical Center, Newark, New Jersey, USA., Abosheaishaa H; Division of Gastroenterology and Hepatology, Brooklyn Health Center, Brooklyn, New York, USA., Elfert K; Division of Gastroenterology and Hepatology, West Virginia University School of Medicine, Morgantown, West Virginia, USA., Sharma A; Faculty of Medicine, Monash University/Monash Health, Victoria, Melbourne, Australia., Andrawes S; Division of Gastroenterology and Hepatology, Staten Island University Hospital-Northwell Health, Staten Island, New York, USA., Duong N; Division of Gastroenterology and Hepatology, Stanford University, Palo Alto, California, USA. |
| Source: | United European gastroenterology journal [United European Gastroenterol J] 2026 Jun; Vol. 14 (5), pp. e70238. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 101606807 Publication Model: Print Cited Medium: Internet ISSN: 2050-6414 (Electronic) Linking ISSN: 20506406 NLM ISO Abbreviation: United European Gastroenterol J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2050-6414 |
|---|---|
| DOI: | 10.1002/ueg2.70238 |